Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Windtree Therapeutics, Inc.”

4 pharma patents match "Windtree Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "Windtree Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “Windtree Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12343350

    Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)

    Windtree Therapeutics, Inc. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted

  2. US 11583540

    Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)

    Windtree Therapeutics, Inc. · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  3. US 11197869

    Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)

    Windtree Therapeutics, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  4. US 9554999

    Lyophilization of synthetic liposomal pulmonary surfactant

    Windtree Therapeutics, Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.